Inventor · Westfield, NJ, US

John E. Stelmach

13Patents
5h-index
64Co-inventors
65Inventor score

Filing activity: Dec 17, 2001 → Jun 27, 2018

Most-cited inventions

PatentTitleAreaCited byStatus
US6809199B2 (Halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents Chemistry; Metallurgy 20 Expired
US7687534B2 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use Human Necessities 19 Active
US9365574B2 Soluble guanylate cyclase activators Chemistry; Metallurgy 18 Active
US8741910B2 Soluble guanylate cyclase activators Chemistry; Metallurgy 12 Active
US9284301B2 Soluble guanylate cyclase activators Chemistry; Metallurgy 9 Active
US7968589B2 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use Human Necessities 4 Active
US10030027B2 Soluble guanylate cyclase stimulators Chemistry; Metallurgy 3 Active
US8318760B2 Substituted aryl and heteroaryl derivatives, compositions containing such compounds and methods of use Chemistry; Metallurgy 1 Active
US7314873B2 (Halo-benzo carbonyl)heterobi cyclic p38 linase inhibiting agents Human Necessities 1 Expired
US10428076B2 Soluble guanylate cyclase stimulators Chemistry; Metallurgy 0 Active
US10968210B2 Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels Chemistry; Metallurgy 0 Active
US8445538B2 Glucagon receptor antagonist compounds Chemistry; Metallurgy 0 Active
US8436015B2 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.